Загрузка...
Immune Checkpoint Therapies in Prostate Cancer
Advanced prostate cancer is the second leading cause of death from cancer in the United States. In the era of cancer immunotherapy, it was the first malignancy to demonstrate improved survival with a cancer-specific vaccine; thus, proving that prostate cancer is an immune responsive disease. However...
Сохранить в:
| Опубликовано в: : | Cancer J |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847149/ https://ncbi.nlm.nih.gov/pubmed/27111907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000176 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|